The relationship between anemia and obesity.
Saad RA, Qutob HM.
Expert Rev Hematol. 2022 Oct;15(10):911-926. doi: 10.1080/17474086.2022.2131521. Epub 2022 Oct 13.
[Diagnosis and therapy of anemia in general practice].
Merlo CM, Wuillemin WA.
Praxis (Bern 1994). 2009 Feb 18;98(4):191-9. doi: 10.1024/1661-8157.98.4.191.
Pathogenesis of renal anemia.
Nangaku M, Eckardt KU.
Semin Nephrol. 2006 Jul;26(4):261-8. doi: 10.1016/j.semnephrol.2006.06.001.
[Anemia of chronic kidney disease: Protocol of study, management and referral to Nephrology].
Cases A, Egocheaga MI, Tranche S, Pallarés V, Ojeda R, Górriz JL, Portolés JM.
Aten Primaria. 2018 Jan;50(1):60-64. doi: 10.1016/j.aprim.2017.09.007. Epub 2017 Dec 7.
Hypoxia-inducible factor prolyl hydroxylase inhibitors for anaemia in chronic kidney disease: a clinical practice document by the European Renal Best Practice board of the European Renal Association.
Stoumpos S, Crowe K, Sarafidis P, Barratt J, Bolignano D, Del Vecchio L, Małyszko J, Więcek A, Ortiz A, Cozzolino M.
Nephrol Dial Transplant. 2024 Sep 27;39(10):1710-1730. doi: 10.1093/ndt/gfae075.
The anemia of chronic renal failure. Overview and early erythropoietin experience.
Paganini EP, Garcia J, Abdulhadi M, Lathim D, Giesman J, Weick JK.
Cleve Clin J Med. 1989 Jan-Feb;56(1):79-86. doi: 10.3949/ccjm.56.1.79.
[Anemia in chronic renal insufficiency and chronic failure].
Zahálková J.
Vnitr Lek. 2003 May;49(5):379-82.
Global, regional, and national burden of renal anemia, 1990 to 2019 and prediction to 2050.
Li Y, Gao L, Chen Y, Wang J, Hu Z, Zhao T, Tian H, Wang D, Wang W, Zhang D.
Nephrol Dial Transplant. 2025 Nov 26;40(12):2289-2299. doi: 10.1093/ndt/gfaf102.
Recombinant human erythropoietin.
Schwenk MH, Halstenson CE.
DICP. 1989 Jul-Aug;23(7-8):528-36. doi: 10.1177/1060028089023007-801.
Pre-operative anaemia.
Clevenger B, Richards T.
Anaesthesia. 2015 Jan;70 Suppl 1:20-8, e6-8. doi: 10.1111/anae.12918.
